BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

59.74 -1.99 (-3.22%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 2, 2026 Add to My Watchlist

Price and Volume

Volume	1,953,218
Open	60.71
Bid (Size)	59.55 (100)
Ask (Size)	62.50 (200)
Prev. Close	61.73
Today's Range	59.25 - 61.14
52wk Range	50.76 - 73.51
Shares Outstanding	183,352,255
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗

Today 12:53 EST

This clinical-stage biotech develops therapies for rare muscle diseases using its proprietary FORCE platform and research-driven approach.

Via The Motley Fool

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗

Today 12:49 EST

This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.

Via The Motley Fool

Performance

YTD	+0.5%	+0.5%
1 Month	+5.7%	+5.7%
3 Month	+8.6%	+8.6%
6 Month	+1.1%	+1.1%
1 Year	-15.9%	-15.9%

More News

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Reports Q4 2025 Revenue Beat and EPS Miss ↗

February 23, 2026

Via Chartmill

BioMarin Pharmaceutical’s (NASDAQ:BMRN) Q4 CY2025 Sales Beat Estimates

February 23, 2026

Via StockStory

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗

January 24, 2026

Via Chartmill

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Emerges as a 'Decent Value' Candidate ↗

January 02, 2026

Via Chartmill

BioMarin Pharmaceutical Earnings: What To Look For From BMRN

February 21, 2026

Via StockStory

Should You Buy BioMarin Pharmaceutical Before Feb. 18? ↗

January 31, 2026

Via The Motley Fool

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

January 08, 2026

Via StockStory

The Great Unlocking: 2026 Opens with a Historic Surge in Large-Cap M&A Activity

January 06, 2026

Via MarketMinute

Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal ↗

December 19, 2025

Via Stocktwits

10 Magnificent Stocks That Can Make You Richer in 2026 ↗

January 05, 2026

Via The Motley Fool

BioMarin’s $4.8 Billion Amicus Acquisition: A Strategic Pivot to Rare Disease Dominance

January 02, 2026

Via MarketMinute

Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal

December 29, 2025

Via MarketMinute

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Group plc (NYSE - JHG), Amicus Therapeutics, Inc. (Nasdaq

December 23, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

December 23, 2025

Via StockStory

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

December 19, 2025

Via StockStory

Which stocks are gapping on Friday? ↗

December 19, 2025

Via Chartmill

1 Oversold Stock Primed to Rebound and 2 That Underwhelm

December 15, 2025

Via StockStory

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗

December 08, 2025

Via Chartmill

Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗

December 03, 2025

Via The Motley Fool

PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗

December 03, 2025

Via The Motley Fool

Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗

December 03, 2025

Via The Motley Fool

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

2 Reasons to Like BMRN and 1 to Stay Skeptical

November 24, 2025

Via StockStory

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?

Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.

What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?

BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?

The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market

What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?

The current price of BioMarin Pharmaceutical Inc. - Common Stock is 59.74

When was BioMarin Pharmaceutical Inc. - Common Stock last traded?

The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 03/02/26 04:00 PM ET

What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?

The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.95B

How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?

BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.